Global Hepatitis B Immune Globulin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hepatitis B Immune Globulin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Hepatitis B immune globulin (HBIG) is a type of blood product made from human plasma that contains antibodies against the hepatitis B virus. It is typically given by injection and is used to prevent or treat hepatitis B infection
Global Hepatitis B Immune Globulin market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Liver Transplant Patients and Newborn Baby are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hepatitis B Immune Globulin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Hepatitis B Immune Globulin key manufacturers include ADMA Biologics, Bio Products Laboratory, Grifols, Biotest AG, CSL Behring, FFF Enterprises and Cleveland Clinic, etc. ADMA Biologics, Bio Products Laboratory, Grifols are top 3 players and held % sales share in total in 2022.
Hepatitis B Immune Globulin can be divided into Intravenous Injection and Intramuscular Injection, etc. Intravenous Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Hepatitis B Immune Globulin is widely used in various fields, such as Liver Transplant Patients, Newborn Baby and Others,, etc. Liver Transplant Patients provides greatest supports to the Hepatitis B Immune Globulin industry development. In 2022, global % sales of Hepatitis B Immune Globulin went into Liver Transplant Patients filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hepatitis B Immune Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
ADMA Biologics
Bio Products Laboratory
Grifols
Biotest AG
CSL Behring
FFF Enterprises
Cleveland Clinic
Segment by Type
Intravenous Injection
Intramuscular Injection
Liver Transplant Patients
Newborn Baby
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Hepatitis B Immune Globulin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hepatitis B Immune Globulin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hepatitis B Immune Globulin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hepatitis B Immune Globulin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hepatitis B Immune Globulin introduction, etc. Hepatitis B Immune Globulin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Hepatitis B Immune Globulin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Global Hepatitis B Immune Globulin market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Liver Transplant Patients and Newborn Baby are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hepatitis B Immune Globulin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Hepatitis B Immune Globulin key manufacturers include ADMA Biologics, Bio Products Laboratory, Grifols, Biotest AG, CSL Behring, FFF Enterprises and Cleveland Clinic, etc. ADMA Biologics, Bio Products Laboratory, Grifols are top 3 players and held % sales share in total in 2022.
Hepatitis B Immune Globulin can be divided into Intravenous Injection and Intramuscular Injection, etc. Intravenous Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Hepatitis B Immune Globulin is widely used in various fields, such as Liver Transplant Patients, Newborn Baby and Others,, etc. Liver Transplant Patients provides greatest supports to the Hepatitis B Immune Globulin industry development. In 2022, global % sales of Hepatitis B Immune Globulin went into Liver Transplant Patients filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hepatitis B Immune Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
ADMA Biologics
Bio Products Laboratory
Grifols
Biotest AG
CSL Behring
FFF Enterprises
Cleveland Clinic
Segment by Type
Intravenous Injection
Intramuscular Injection
Segment by Application
Liver Transplant Patients
Newborn Baby
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Hepatitis B Immune Globulin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hepatitis B Immune Globulin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hepatitis B Immune Globulin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hepatitis B Immune Globulin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hepatitis B Immune Globulin introduction, etc. Hepatitis B Immune Globulin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Hepatitis B Immune Globulin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices